FDA’s novel medical device clearances slow to a crawl
According to the FDA’s public database, since the start of this year the agency has issued only two de novo clearances, far below its quarterly average.
According to the FDA’s public database, since the start of this year the agency has issued only two de novo clearances, far below its quarterly average.
